J. Chow

发表

Kinetic mechanism of enterococcal aminoglycoside phosphotransferase 2"-Ib.

J. Zajicek, S. Mobashery, M. Tóth, 2007, Biochemistry.

An outbreak of infusion-related Klebsiella pneumoniae bacteremia in a liver transplantation unit.

J. Chow, A. Goetz, J. Rihs, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Multiplex PCR for Detection of Aminoglycoside Resistance Genes in Enterococci

M. Zervos, J. Chow, S. Vakulenko, 2003, Antimicrobial Agents and Chemotherapy.

In vitro susceptibilities of Escherichia coli isolated from patients with intra-abdominal infections worldwide in 2002-2004: results from SMART (Study for Monitoring Antimicrobial Resistance Trends).

F. Baquero, D. Paterson, G. Bochicchio, 2006, Surgical infections.

Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy.

V L Yu, M. Fine, J. Quinn, 1991, Annals of internal medicine.

Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance

J. Boyce, A. Medeiros, S. Opal, 1994, Journal of clinical microbiology.

Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals in two states

M. Zervos, J. Chow, D. Shlaes, 1993, Journal of clinical microbiology.

PCR Fragment Length Polymorphism Analysis of Vancomycin-Resistant Enterococcus faecium

B. Robinson-Dunn, M. Zervos, J. Chow, 2000, Journal of Clinical Microbiology.

Molecular Analysis of Glycopeptide-ResistantEnterococcus faecium Isolates Collected from Michigan Hospitals over a 6-Year Period

Don B. Clewell, Marcus J. Zervos, B. Robinson-Dunn, 1998, Journal of Clinical Microbiology.

DNA hybridization and contour-clamped homogeneous electric field electrophoresis for identification of enterococci to the species level

M. Zervos, J. Chow, D. Shlaes, 1995, Journal of clinical microbiology.

A Prospective, Multicenter Study of Caspofungin for the Treatment of Documented Candida or Aspergillus Infections in Pediatric Patients

H. Jafri, F. Locatelli, W. Ebell, 2009, Pediatrics.

In-vitro activity of arbekacin alone and in combination with vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus.

M. Zervos, H. Kumon, J. Chow, 2000, Diagnostic microbiology and infectious disease.

Safety Profile of Ceftazidime–Avibactam: Pooled Data from the Adult Phase II and Phase III Clinical Trial Programme

J. Chow, David Wilson, K. Cheng, 2020, Drug Safety.

Acquired Antibiotic Resistances in Enterococci

J. Chow, V. Kak, 2002 .

In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends).

F. Baquero, D. Paterson, G. Bochicchio, 2006, The Journal of antimicrobial chemotherapy.

Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary.

V. Yu, J. Chow, 1999, International Journal of Antimicrobial Agents.

Structures, Locations, and Transfer Frequencies of Genetic Elements Conferring High-Level Gentamicin Resistance in Enterococcus faecalis Isolates in Greece

M. Zervos, J. Chow, G. Petrikkos, 2003, Antimicrobial Agents and Chemotherapy.

Molecular analysis of vancomycin-resistant Enterococcus faecalis from Michigan hospitals during a 10 year period.

B. Robinson-Dunn, P. Malani, M. Zervos, 2002, The Journal of antimicrobial chemotherapy.

Heteroresistance to Vancomycin inEnterococcus faecium

M. Zervos, J. Chow, S. Donabedian, 2001, Journal of Clinical Microbiology.

Antimicrobial Resistance in Enterococci Isolated from Turkey Flocks Fed Virginiamycin

M. Zervos, J. Chow, S. Donabedian, 1998, Antimicrobial Agents and Chemotherapy.

A New High-Level Gentamicin Resistance Gene,aph(2")-Id, in Enterococcus spp

M. Zervos, J. Chow, D. Clewell, 1998, Antimicrobial Agents and Chemotherapy.

Clinical and Microbiological Outcomes of Ceftazidime-Avibactam Treatment in Adults with Gram-Negative Bacteremia: A Subset Analysis from the Phase 3 Clinical Trial Program

Y. Carmeli, J. Mazuski, A. Torres, 2021, Infectious Diseases and Therapy.

A randomised, double-blind, phase 3 study comparing the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem for complicated intra-abdominal infections in hospitalised adults in Asia.

Binh Giang Tran, X. Qin, J. Chow, 2017, International journal of antimicrobial agents.

In vitro susceptibilities of aerobic and facultatively anaerobic gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2005 results from Study for Monitoring Antimicrobial Resistance Trends (SMART).

F. Baquero, D. Paterson, G. Bochicchio, 2009, Surgical infections.

In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends).

P. Hsueh, J. Chow, M. Dinubile, 2006, International journal of antimicrobial agents.

Group A streptococcal meningitis.

J. Chow, R. Muder, 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Imipenem resistance associated with the loss of a 40 kDa outer membrane protein in Enterobacter aerogenes.

J. Chow, D. Shlaes, 1991, The Journal of antimicrobial chemotherapy.

Is pneumonia really the old man's friend? Two-year prognosis after community-acquired pneumonia

V. Yu, F. Brancati, J. Chow, 1993, The Lancet.

Characterization of antimicrobial resistance in enterococci of animal origin

M. Zervos, J. Chow, M. Perri, 1995, Antimicrobial agents and chemotherapy.

Staphylococcus aureus nasal carriage in hemodialysis patients. Its role in infection and approaches to prophylaxis.

V. Yu, J. Chow, 1989, Archives of internal medicine.

In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART).

F. Baquero, H. Teppler, D. Paterson, 2005, The Journal of antimicrobial chemotherapy.

In vitro susceptibilities of aerobic and facultative gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2002 Study for Monitoring Antimicrobial Resistance Trends (SMART).

J. Chow, Charlotte M. Harvey, M. Dinubile, 2005, Surgical infections.

SAFETY EXPERIENCE WITH CASPOFUNGIN IN PEDIATRIC PATIENTS

H. Jafri, J. Chow, W. Steinbach, 2009, The Pediatric infectious disease journal.

Purification, crystallization and preliminary X-ray analysis of Enterococcus faecium aminoglycoside-2''-phosphotransferase-Ib [APH(2'')-Ib].

H. Baker, E. Baker, P. Young, 2005, Acta crystallographica. Section F, Structural biology and crystallization communications.

Source of Phosphate in the Enzymic Reaction as a Point of Distinction among Aminoglycoside 2″-Phosphotransferases*

S. Mobashery, M. Tóth, J. Chow, 2009, Journal of Biological Chemistry.

Antibiotic studies in pneumonia. Pitfalls in interpretation and suggested soluions.

V. Yu, J. Chow, 1989, Chest.

Staphylococcal Infections in the Hemodialysis Unit: Prevention Using Infection Control Principles

V. Yu, J. Chow, A. Goetz, 1988, Infection Control & Hospital Epidemiology.

Aminoglycoside resistance in enterococci.

J. Chow, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

SPECIAL SECTION: ANTIMICROBIAL RESISTANCE

G. Eliopoulos, J. Dingell, J. Chow, 2000 .

In vitro susceptibility and molecular analysis of gentamicin-resistant enterococci.

M. Zervos, J. Chow, D. Clewell, 1998, Diagnostic microbiology and infectious disease.

Clinical activity of ceftazidime/avibactam against MDR Enterobacteriaceae and Pseudomonas aeruginosa: pooled data from the ceftazidime/avibactam Phase III clinical trial programme

J. Chow, G. Stone, L. Gasink, 2018, The Journal of antimicrobial chemotherapy.

Emergence of increased resistance to quinupristin/dalfopristin during therapy for Enterococcus faecium bacteremia.

M. Zervos, J. Chow, S. Donabedian, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pharmacokinetics and Safety of Caspofungin in Neonates and Infants Less than 3 Months of Age

H. Jafri, J. Chow, N. Kartsonis, 2008, Antimicrobial Agents and Chemotherapy.

In vitro activity of sparfloxacin and clinafloxacin against multidrug-resistant enterococci.

M. Zervos, J. Chow, M. Perri, 1993, Diagnostic microbiology and infectious disease.

Quantitative comparison in vitro of mutational antibiotic resistance of Enterobacter spp. using a spiral plater.

V. Yu, J. Chow, C. M. Yu, 1996, The Journal of antimicrobial chemotherapy.

Epidemiologic perspectives on Enterobacter for the infection control professional.

V. Yu, J. Chow, D. Shlaes, 1994, American journal of infection control.

Detection of the High-Level Aminoglycoside Resistance Gene aph(2")-Ib in Enterococcus faecium

M. Zervos, J. Chow, D. Clewell, 2000, Antimicrobial Agents and Chemotherapy.

Molecular characterization of highly gentamicin-resistant Enterococcus faecalis isolates lacking high-level streptomycin resistance

M. Zervos, J. Chow, D. Clewell, 1993, Antimicrobial Agents and Chemotherapy.

Synergy assessed by checkerboard. A critical analysis.

V. Yu, M. Hsieh, J. Chow, 1993, Diagnostic microbiology and infectious disease.

Caspofungin Versus Liposomal Amphotericin B: Are They Really Comparable?

H. Jafri, C. Arndt, T. Walsh, 2010 .

A Randomized, Double-Blind, Multicenter Study of Caspofungin Versus Liposomal Amphotericin B for Empiric Antifungal Therapy in Pediatric Patients With Persistent Fever and Neutropenia

H. Jafri, C. Arndt, T. Walsh, 2010, The Pediatric infectious disease journal.

Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: a prospective, multicenter study of 91 episodes.

K. Papadakis, M. Edmond, J. Chow, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial.

M. Kollef, J. Timsit, N. Zhong, 2017, The Lancet. Infectious diseases.

Association between the presence of enterococcal virulence factors gelatinase, hemolysin, and enterococcal surface protein and mortality among patients with bacteremia due to Enterococcus faecalis.

D. Snydman, M. Zervos, J. Chow, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Quinupristin-Dalfopristin Resistance in Enterococcus faecium Isolates from Humans, Farm Animals, and Grocery Store Meat in the United States

M. Zervos, J. Chow, F. Angulo, 2006, Journal of Clinical Microbiology.

Molecular Characterization of Gentamicin-Resistant Enterococci in the United States: Evidence of Spread from Animals to Humans through Food

J. R. Johnson, M. Zervos, J. Chow, 2003, Journal of Clinical Microbiology.

Simple and Reliable Multiplex PCR Assay for Surveillance Isolates of Vancomycin-Resistant Enterococci

H. Kumon, J. Chow, D. Clewell, 2000, Journal of Clinical Microbiology.

Aminoglycoside Resistance Genesaph(2")-Ib and aac(6′)-Im Detected Together in Strains of both Escherichia coli andEnterococcus faecium

J. Chow, D. Clewell, S. Lerner, 2001, Antimicrobial Agents and Chemotherapy.

Efficacy of Ampicillin plus Arbekacin in Experimental Rabbit Endocarditis Caused by an Enterococcus faecalis Strain with High-Level Gentamicin Resistance

M. Zervos, H. Kumon, J. Chow, 2000, Antimicrobial Agents and Chemotherapy.

The production of a novel carbapenem-hydrolysing lactamase in Aeromonas veronii biovar sobria , and its association with imipenem resistance

M. Zervos, H. Kumon, J. Chow, 1998 .

Mutations in the aph(2")-Ic Gene Are Responsible for Increased Levels of Aminoglycoside Resistance

J. Chow, S. Vakulenko, D. Clewell, 2002, Antimicrobial Agents and Chemotherapy.

In-vitro synergistic activity of the combination of ampicillin and arbekacin against vancomycin-and high-level gentamicin-resistant Enterococcus faecium with the aph(2")-Id gene.

M. Zervos, H. Kumon, J. Chow, 2000, Diagnostic microbiology and infectious disease.

Plasmid-associated hemolysin and aggregation substance production contribute to virulence in experimental enterococcal endocarditis

M. Zervos, J. Chow, D. Clewell, 1993, Antimicrobial Agents and Chemotherapy.

Plasmid Content of a Vancomycin-Resistant Enterococcus faecalis Isolate from a Patient Also Colonized by Staphylococcus aureus with a VanA Phenotype

M. Zervos, J. Chow, Y. Ozawa, 2003, Antimicrobial Agents and Chemotherapy.

Infants Less than 3 Months of Age

H. Jafri, J. Chow, N. Kartsonis, 2008 .

Aminoglycoside 2″-Phosphotransferase Type IIIa from Enterococcus*

J. Zajicek, S. Mobashery, J. Chow, 2008, Journal of Biological Chemistry.

A novel gentamicin resistance gene in Enterococcus

S. Tsai, M. Zervos, J. Chow, 1997, Antimicrobial agents and chemotherapy.

Molecular typing of ampicillin-resistant, non-beta-lactamase-producing Enterococcus faecium isolates from diverse geographic areas

P. Coudron, J. Boyce, M. Zervos, 1992, Journal of clinical microbiology.

Bowel colonization with vancomycin-resistant enterococci after antimicrobial therapy for intra-abdominal infections: observations from 2 randomized comparative clinical trials of ertapenem therapy.

J. Quinn, R. Weinstein, M. Shivaprakash, 2007, Diagnostic microbiology and infectious disease.

Acquisition of Resistant Bowel Flora during a Double-Blind Randomized Clinical Trial of Ertapenem versus Piperacillin-Tazobactam Therapy for Intraabdominal Infections

H. Teppler, M. Motyl, J. Chow, 2005, Antimicrobial Agents and Chemotherapy.

In Vitro Activity of Ceftazidime-Avibactam against Isolates from Respiratory and Blood Specimens from Patients with Nosocomial Pneumonia, Including Ventilator-Associated Pneumonia, in a Phase 3 Clinical Trial

P. Bradford, J. Chow, G. Stone, 2020, Antimicrobial Agents and Chemotherapy.

Mobilization of the penicillinase gene in Enterococcus faecalis

M. Zervos, J. Chow, M. Perri, 1993, Antimicrobial Agents and Chemotherapy.

Legionella: a major opportunistic pathogen in transplant recipients.

V. Yu, J. Chow, 1998, Seminars in respiratory infections.

Superinfection with Enterococcus faecalis during quinupristin/dalfopristin therapy.

M. Zervos, J. Chow, A. Davidson, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Caspofungin exposure‐response relationships in adult patients with mucosal or invasive candidiasis

J. Chow, N. Kartsonis, C. Sable, 2014, Clinical pharmacology in drug development.

Pharmacokinetics and Safety of Caspofungin in Neonates and Infants Less than 3 Months of Age (cid:1)

H. Jafri, J. Chow, N. Kartsonis, 2009 .

Staphylococcal infections in the hemodialysis unit: prevention using infection control principles.

V. Yu, J. Chow, A. Goetz, 1988, Infection control and hospital epidemiology.

Corrigendum to "In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends)" (Int. J. Antimicrob. Agents 28 (2006) 238-243)

P. Hsueh, J. Chow, M. Dinubile, 2009 .

Mutant APH(2″)-IIa Enzymes with Increased Activity against Amikacin and Isepamicin

M. Tóth, J. Chow, Clyde A. Smith, 2010, Antimicrobial Agents and Chemotherapy.

Phase 3, Randomized, Double-blind Noninferiority (NI) Study of Ceftazidime–Avibactam (CAZ-AVI) vs. Meropenem (MER) in the Treatment of Patients with Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia (HABP/VABP): Analyses of the REPROVE Study per US FDA Endpoints

A. Torres, T. Riccobene, H. Lakkis, 2017 .

Tn924, a chromosome-borne transposon encoding high-level gentamicin resistance in Enterococcus faecalis

M. Zervos, J. Chow, D. Clewell, 1994, Antimicrobial Agents and Chemotherapy.

Failure of oral ciprofloxacin in suppressing Staphylococcus aureus carriage in haemodialysis patients.

V. Yu, J. Chow, 1992, The Journal of antimicrobial chemotherapy.